Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103 Meeting Abstract
| Authors: | Wilson, W. H.; Porcu, P.; Hurd, D.; Martin, S. E.; Czuczman, M.; Niedzwiecki, D.; Saint Louis, J. D.; Johnson, J. L.; Cheson, B.; Canellos, G. P.; Zelenetz, A. D. |
| Abstract Title: | Phase II study of dose-adjusted EPOCH-R in untreated de novo CD20+ diffuse large B-cell lymphoma (DLBCL)-CALGB 50103 |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 567S |
| Language: | English |
| ACCESSION: | WOS:000230326603487 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.6530 |
| Notes: | --- - Meeting Abstract: 6530 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - "1" - "Source: Wos" |
